The vaccines space has traditionally been the preserve of a select group of companies but the pandemic has changed it all quite markedly, at least in India.
There’s been a stream of conventionally non-vaccine biopharma firms keen to tap into the segment, essentially via alliances for now
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?